ENDONOVO THERAPEUTICS, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
ENDONOVO THERAPEUTICS, INC. (ENDV) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $646.19 thousand as of 2023-09-30, per its 10-Q filed 2023-12-29.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2023-12-29
- 2023-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $646.19K.
- 2023-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $646.91K.
- 2023-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $646.91K.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $646.91K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2023-09-30 | $646.19K 10-Q · filed 2023-12-29 |
| 2023-06-30 | $646.91K 10-Q · filed 2023-08-21 |
| 2023-03-31 | $646.91K 10-Q · filed 2023-05-22 |
| 2022-12-31 | $646.91K 10-K · filed 2023-04-17 |
| 2022-09-30 | $646.91K 10-Q · filed 2022-11-21 |
| 2022-06-30 | $646.91K 10-Q · filed 2022-08-22 |
| 2022-03-31 | $646.91K 10-Q · filed 2022-05-19 |
| 2021-12-31 | $646.91K 10-K · filed 2022-04-14 |
| 2021-09-30 | $646.91K 10-Q · filed 2021-11-19 |
| 2021-06-30 | $646.91K 10-Q · filed 2021-08-23 |
| 2021-03-31 | $646.91K 10-Q · filed 2021-05-24 |
| 2020-12-31 | $646.91K 10-K · filed 2021-04-13 |
| 2020-09-30 | $646.91K 10-Q · filed 2020-11-19 |
| 2020-06-30 | $646.91K 10-Q · filed 2020-08-19 |
| 2020-03-31 | $646.91K 10-Q · filed 2020-06-12 |
| 2019-12-31 | $646.91K 10-K · filed 2020-05-04 |
| 2019-09-30 | $646.91K 10-Q · filed 2019-11-19 |
| 2019-06-30 | $646.91K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $646.91K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $646.91K 10-K · filed 2019-04-15 |
| 2018-09-30 | $646.91K 10-Q · filed 2018-11-13 |